A portfolio model of drug development for tuberculosis

Journal Article

Because of inadequate funding and the lack of promising drugs, no new antituberculosis drugs are likely to become available before 2010.

Full Text

Duke Authors

Cited Authors

  • Glickman, SW; Rasiel, EB; Hamilton, CD; Kubataev, A; Schulman, KA

Published Date

  • 2006

Published In

Volume / Issue

  • 311 / 5765

Start / End Page

  • 1246 - 1247

International Standard Serial Number (ISSN)

  • 0036-8075

Digital Object Identifier (DOI)

  • 10.1126/science.1119299